Arcus Biosciences, Inc. (RCUS)
$30.12-0.73%Close
BUYRECOVERY · day 15
Key stats
- Market cap
- $3.8B
- Avg volume
- 1.3M
- Beta
- 0.81
- P/E (TTM)
- -7.66
- 1W
- +1.89%
- 1M
- +5.98%
- 3M
- +28.55%
- YTD
- +29.33%
- vs SPY 1W
- +3.09%
- vs SPY 1M
- +2.66%
- vs SPY 3M
- +26.16%
- vs SPY YTD
- +17.57%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ABCLBUYAbCellera Biologics Inc.RECOVERYQ -7$10.61-6.27%
- COYABUYCoya Therapeutics, Inc.RECOVERYQ 9$4.96+1.85%
- CNTBBUYConnect Biopharma Holdings LimitedRECOVERYQ -12$2.30-2.54%
- KYMRBUYKymera Therapeutics, Inc.BULLQ 27$121.05+1.04%
- ROIVBUYRoivant Sciences Ltd.BULLQ 31$36.36+0.17%
- CTSOSELLCytosorbents CorporationCRISISQ 2$0.37+0.00%
- CGONBUYCG Oncology, Inc. Common stockBULLQ 32$78.23-1.98%
- DNLIBUYDenali Therapeutics Inc.RECOVERYQ 10$24.20-2.89%
- ANGOBUYAngioDynamics, Inc.BULLQ 5$15.77+0.13%
- ESTASELLEstablishment Labs Holdings Inc.CRISISQ 17$72.06-0.84%
- FHTXBUYFoghorn Therapeutics Inc.RECOVERYQ 4$6.87-2.83%
- JAGXBUYJaguar Health, Inc.CRISISQ -29$0.91+4.60%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 4
- VALUE
- 3
- GROWTH
- 17
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-52.8%
REV YoY-
ROE-88.0%
EPS YoY-
ROA-48.9%
GROSS94
OP-415
NET-386
[VALUATION]
P/E TTM-7.66
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B8.19
P/FCF-
EV/EBITDA-8.96
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E24.57
ALTMAN Z-
CURR RATIO3.82
ND/EBITDA-
BETA0.81
Company news
Loading headlines…